These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7150368)

  • 1. Correction of drug binding defects in uremia in vitro by anion exchange resin treatment.
    Lichtenwalner DM; Suh B; Lorber B; Rudnick MR; Craig WA
    Biochem Pharmacol; 1982 Nov; 31(21):3483-7. PubMed ID: 7150368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification and characterization of the drug-binding-defect inducer in uremia.
    Lichtenwalner DM; Suh B; Lorber B; Rudnick MR; Craig WA
    J Lab Clin Med; 1981 Jan; 97(1):72-81. PubMed ID: 7452082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired plasma phenytoin binding in uremia. Effect of in vitro acidification and anion-exchange resin.
    Depner TA; Stanfel LA; Jarrard EA; Gulyassy PF
    Nephron; 1980; 25(5):231-7. PubMed ID: 7383235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma protein binding in uremia: extraction and characterization of an inhibitor.
    Depner TA; Gulyassy PF
    Kidney Int; 1980 Jul; 18(1):86-94. PubMed ID: 7218662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of protein binding defect in uremic sera by charcoal treatment.
    Craig WA; Evenson MA; Sarver KP; Wagnild JP
    J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma protein carbamylation and decreased acidic drug protein binding in uremia.
    Erill S; Calvo R; Carlos R
    Clin Pharmacol Ther; 1980 May; 27(5):612-8. PubMed ID: 7371359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of isohydric hemodialysis on the binding and removal of uremic retention solutes.
    Etinger A; Kumar SR; Ackley W; Soiefer L; Chun J; Singh P; Grossman E; Matalon A; Holzman RS; Meijers B; Lowenstein J
    PLoS One; 2018; 13(2):e0192770. PubMed ID: 29470534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serum.
    Mabuchi H; Nakahashi H
    Ther Drug Monit; 1988; 10(3):261-4. PubMed ID: 3140432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of salicylate binding to normal plasma by extracts of uremic fluids.
    Roman S; Gulyassy PF; Depner TA
    Am J Kidney Dis; 1984 Sep; 4(2):153-61. PubMed ID: 6475946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein binding of drugs in uremic and normal serum: the role of endogenous binding inhibitors.
    Sjöholm I; Kober A; Odar-Cederlöf I; Borgåa O
    Biochem Pharmacol; 1976 May; 25(10):1205-13. PubMed ID: 938543
    [No Abstract]   [Full Text] [Related]  

  • 12. Endogenous accumulation products and serum protein binding in uremia.
    McNamara PJ; Lalka D; Gibaldi M
    J Lab Clin Med; 1981 Nov; 98(5):730-40. PubMed ID: 7299243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aromatic amino acid metabolites as potential protein binding inhibitors in human uremic plasma.
    Tavares-Almeida I; Gulyassy PF; Depner TA; Jarrard EA
    Biochem Pharmacol; 1985 Jul; 34(14):2431-8. PubMed ID: 4015686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Underestimation of serum albumin by the bromcresol purple method and a major endogenous ligand in uremia.
    Mabuchi H; Nakahashi H
    Clin Chim Acta; 1987 Jul; 167(1):89-96. PubMed ID: 3665090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of disease states on plasma protein binding of drugs.
    Reidenberg MM
    Med Clin North Am; 1974 Sep; 58(5):1103-9. PubMed ID: 4607741
    [No Abstract]   [Full Text] [Related]  

  • 16. Biophysical studies on the correction of uremic human serum albumin binding defects by in vitro charcoal adsorption treatment.
    Nikolaev V; Sarnatskaya V; von Appen K; Ivanov A; Rotellar E; Haspar M; Klinkmann H
    Artif Organs; 1996 Jan; 20(1):17-23. PubMed ID: 8645124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein binding of diazepam and digitoxin in uremic and normal serum.
    Kober A; Sjöholm I; Borgå O; Odar-Cederlöf I
    Biochem Pharmacol; 1979 Apr; 28(7):1037-42. PubMed ID: 444260
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced in vitro binding of tryptophan by plasma in uremia.
    de Torrente A; Glazer GB; Gulyassy P
    Kidney Int; 1974 Oct; 6(4):222-9. PubMed ID: 4427418
    [No Abstract]   [Full Text] [Related]  

  • 19. Accumulation of furancarboxylic acids in uremic serum as inhibitors of drug binding.
    Niwa T; Takeda N; Maeda K; Shibata M; Tatematsu A
    Clin Chim Acta; 1988 Apr; 173(2):127-38. PubMed ID: 3378354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased binding of quinidine to serum albumin and lipoproteins in anuric rats.
    Nilsen OG; Fremstad D; Jacobsen S
    Eur J Pharmacol; 1975 Aug; 33(1):131-9. PubMed ID: 1175679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.